S. 134, Alzheimer’s Accountability and Investment Act
As reported by the Senate Committee on Health, Education, Labor, and Pensions on July 27, 2023
By Fiscal Year, Millions of Dollars
2024
2024-2028
2024-2033
Direct Spending (Outlays)
0
0
0
Revenues
0
0
0
Increase or Decrease (-) in the Deficit
0
0
0
Spending Subject to Appropriation (Outlays)
0
0
not estimated
Increases net direct spending in any of the four consecutive 10-year periods beginning in 2034?
No
Statutory pay-as-you-go procedures apply?
No
Mandate Effects
Increases on-budget deficits in any of the four consecutive 10-year periods beginning in 2034?
No
Contains intergovernmental mandate?
No
Contains private-sector mandate?
No
Summary
S. 134 would require the National Institutes of Health to prepare annual estimates of the costs of research conducted under the National Alzheimer’s Project Act. Those estimates would be submitted to the President for review and transmittal to the Congress. Because the agency already provides such information, CBO estimates that implementing S. 134 would have no additional effect on the federal budget.